New Non-Nucleocide NS5B Protein Inhibitors for the Treatment of Chronic Hepatitis C Infection

E-ISSN： 1873-4294|16|12|1392-1401

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.12, 2016-03, pp. : 1392-1401

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection

By Herbst D Alan Reddy K Rajender

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1337-1346

Informa Healthcare

Access to resources Recommend Favorite

New NS5B polymerase inhibitors for hepatitis C

By Legrand-Abravanel Florence Nicot Florence Izopet Jacques

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 963-975

Informa Healthcare

Access to resources Recommend Favorite

Discovery and Development of Hepatitis C Virus Inhibitors Targeting the NS5A Protein

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 7, 2015-06 ,pp. : 553-581

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis C therapy with HCV NS5B polymerase inhibitors

By Soriano Vincent Vispo Eugenia de Mendoza Carmen Labarga Pablo Fernandez-Montero Jose Vicente Poveda Eva Treviño Ana Barreiro Pablo

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1161-1170

Informa Healthcare

Access to resources Recommend Favorite

Entecavir: a new treatment for chronic hepatitis B infection

By Schreibman Ian R Schiff Eugene R

Future Virology, Vol. 1, Iss. 5, 2006-09 ,pp. : 541-552

Future Medicine

Access to resources Recommend Favorite